Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Comprehensive Psychiatry|January 14, 2003
Depression in Kraepelinian schizophreniaNael Kilzieh, Amanda Ernst Wood, Jaime Erdmann, et al.Essential Psychopharmacology|September 23, 2006
Abstinence, anticipation, reduction, and treatment (AART): a stepwise approach to the management of atypical antipsychotic side effectsAnnette Kennedy, Andre Tapp, William S Kelly, et al.Psychiatric Services (Washington, D.C.)|January 2, 2003
Combination antipsychotic therapy in clinical practiceAndre Tapp, Amanda Ernst Wood, Lori Secrest, et al.Drug and Alcohol Dependence|February 16, 2015
Quetiapine for the treatment of cocaine use disorderAndre Tapp, Amanda Ernst Wood, Annette Kennedy, et al.Clinical Schizophrenia & Related Psychoses|October 11, 2011
Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE studyMiranda Chakos, Javendra K Patel, Robert Rosenheck, et al.Journal of Clinical Psychopharmacology|March 18, 2008
Quetiapine for the treatment of cocaine dependence: an open-label trialAnnette Kennedy, Amanda Ernst Wood, Andrew J Saxon, et al.Psychiatric Services (Washington, D.C.)|July 28, 2006
Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trialMiranda H Chakos, Ira D Glick, Alexander L Miller, et al.JAMA|July 12, 2017
Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical TrialSomaia Mohamed, Gary R Johnson, Peijun Chen, et al.Pageof 1